Ashland Will Get Pharmachem for $660 Million

C&EN Global Enterprise
doi 10.1021/cen-09517-notw10
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

American Chemical Society (ACS)

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy